{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.196.12.1501",
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1501",
  "identifier": [ {
    "system": "urn:ietf:rfc:3986",
    "value": "2.16.840.1.113883.3.464.1003.196.12.1501"
  } ],
  "version": "20180310",
  "name": "Hyoscyamine",
  "title": "Hyoscyamine",
  "status": "active",
  "experimental": false,
  "publisher": "NLM",
  "expansion": {
    "identifier": "20210506",
    "timestamp": "2021-07-19T17:22:06-06:00",
    "contains": [ {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1037234",
      "display": "benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1046770",
      "display": "12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1046787",
      "display": "atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1046815",
      "display": "atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1046982",
      "display": "hyoscyamine sulfate 0.125 MG Sublingual Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1046985",
      "display": "hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1046997",
      "display": "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1047786",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1047881",
      "display": "hyoscyamine sulfate 0.025 MG/ML Oral Solution"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1047895",
      "display": "hyoscyamine sulfate 0.125 MG/ML Oral Solution"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1047905",
      "display": "hyoscyamine sulfate 0.125 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1047916",
      "display": "1 ML hyoscyamine sulfate 0.5 MG/ML Injection"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1048124",
      "display": "12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1048147",
      "display": "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.3111 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1048307",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1048336",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1050325",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1087365",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1440869",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1598634",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "1807886",
      "display": "Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "2021-01",
      "code": "998726",
      "display": "hyoscyamine sulfate 0.0625 MG / phenyltoloxamine citrate 15 MG Oral Capsule"
    } ]
  }
}